Shazli Naseer, MD
Family Medicine · Fort Worth, TXNPI 1912928987
Payments from drug & device makers
Across 26 payments — averaging $99.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Insulet Corporation$319
- Corcept Therapeutics$159
- Kyowa Kirin, Inc.$19
- Dexcom, Inc.$18
- Tandem Diabetes Care, Inc.$15
- plus $7 from 1 others
What the payments were for
- Travel & lodging$1,29350%
- Food & beverage$1,28450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 17 | $2,039 |
| Insulet Corporation | 3 | $319 |
| Corcept Therapeutics | 2 | $159 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Tandem Diabetes Care, Inc. | 1 | $15 |
| Cequr Corporation | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Minimed 670G System$850
- MINIMED 780G$549
- Omnipod$302
- Korlym$144
How this compares
$2,577 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 80 | $81,067 |
| JardianceEmpagliflozin | 101 | $64,034 |
| Tresiba Flextouch U-100Insulin Degludec | 19 | $9,970 |
| Rosuvastatin Calcium | 36 | $6,680 |
| Metformin Hcl ErMetformin Hcl | 73 | $3,972 |
| Novolog FlexpenInsulin Aspart | 16 | $2,651 |
| Atorvastatin Calcium | 13 | $1,363 |
| SynthroidLevothyroxine Sodium | 26 | $1,309 |
| Metformin Hcl | 18 | $1,208 |
| Enalapril Maleate | 11 | $393 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Fort Worth
- William SegerFort Worth$27.5M
- Mark KochFort Worth$7.6M
- Isaac WatembergFort Worth$3.2M
- James HarveyFort Worth$2.7M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- Veronica FragosoHouston$24.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.